.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Precision oncology is evolving rapidly as researchers explore the deep connections between genomic biomarkers. The integration of HRD and Replication Stress (RS) has emerged as a vital strategy for improving cancer treatment in India and globally. These two hallmarks of genomic instability often occur together and offer unique opportunities for therapeutic targeting.
Recent pan-cancer analyses highlight that combining poly ADP-ribose polymerase inhibitors (PARPi) with immune checkpoint blockade (ICB) increases efficacy significantly. Furthermore, targeting the replication stress response can effectively overcome resistance often seen in mono-therapies. This synergistic approach aims to maximize tumor cell death while maintaining manageable toxicity levels.
Consequently, experts are developing a unified therapeutic axis that focuses on both HRD and RS pathways simultaneously. In addition, novel assays are now helping to identify patients who will benefit most from these next-generation strategies. Therefore, integrating functional assessments with immune contexture will likely become the future standard for guiding precision oncology.
They are interconnected hallmarks of genomic instability. HRD increases susceptibility to DNA damage, while replication stress involves the stalling of replication forks. Together, they create a functional axis for targeted drugs.
Combining PARP inhibitors with replication stress inhibitors or immunotherapy can improve treatment efficacy. This approach often overcomes the resistance found in traditional monotherapy regimens.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Ozmen TY et al. Integrating homologous recombination deficiency and replication stress: converging strategies unlocking new frontiers in precision oncology. Expert Rev Clin Pharmacol. 2026 Apr 26. doi: 10.1080/17512433.2026.2665447. PMID: 42035488.
2. Lord CJ, Ashworth A. PARP inhibitors: Synthetic lethality in the clinic. Science. 2017 Mar 17;355(6330):1152-1158.
3. Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nat Cell Biol. 2014 Jan;16(1):2-9.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This article reviews how the intersection of HRD and replication stress provides a foundation for next-generation, functionally guided cancer treatments....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
